Journal Articles Published In 2026
2775998
TCMBXKKM
2026
1
padagogische-hochschule-bern-institut-vorschulstufe-und-primarstufe
50
date
desc
year
5439
https://www.iedea-sa.org/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3Afalse%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%226EE452TQ%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Schmutz%20et%20al.%22%2C%22parsedDate%22%3A%222026-01-27%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BSchmutz%2C%20Remo%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BBanholzer%2C%20Nicolas%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BShearer%2C%20Kate%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BGolub%2C%20Jonathan%20E.%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BCortes%2C%20Claudia%20P.%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282026%29.%20The%20implementation%20of%20tuberculosis%20preventive%20therapy%20in%20HIV%20care%20clinics%20in%20Africa%2C%20Asia%20and%20Latin%20America%3A%20a%20multiregional%20site%20survey.%20%26lt%3Bi%26gt%3BBMJ%20Global%20Health%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B11%26lt%3B%5C%2Fi%26gt%3B%20%281%29%2C%20S.%20e018469.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmjgh-2024-018469%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1136%5C%2Fbmjgh-2024-018469%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22The%20implementation%20of%20tuberculosis%20preventive%20therapy%20in%20HIV%20care%20clinics%20in%20Africa%2C%20Asia%20and%20Latin%20America%3A%20a%20multiregional%20site%20survey%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Remo%22%2C%22lastName%22%3A%22Schmutz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nicolas%22%2C%22lastName%22%3A%22Banholzer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kate%22%2C%22lastName%22%3A%22Shearer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%20E.%22%2C%22lastName%22%3A%22Golub%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Claudia%20P.%22%2C%22lastName%22%3A%22Cortes%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eug%5Cu00e8ne%22%2C%22lastName%22%3A%22Messou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Nana%22%2C%22lastName%22%3A%22Mbonze%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Joseph%22%2C%22lastName%22%3A%22Musaazi%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Guy%22%2C%22lastName%22%3A%22Muula%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Anggraini%22%2C%22lastName%22%3A%22Alam%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Diana%22%2C%22lastName%22%3A%22Varela%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Armel%22%2C%22lastName%22%3A%22Poda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Ellen%22%2C%22lastName%22%3A%22Brazier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lameck%22%2C%22lastName%22%3A%22Diero%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Cordelia%22%2C%22lastName%22%3A%22Kunzekwenyika%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Awachana%22%2C%22lastName%22%3A%22Jiamsakul%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Vanessa%22%2C%22lastName%22%3A%22Rouzier%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Zannou%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marcel%22%2C%22lastName%22%3A%22Yotebieng%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leslie%20A.%22%2C%22lastName%22%3A%22Enane%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Dickman%22%2C%22lastName%22%3A%22Gareta%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jorge%22%2C%22lastName%22%3A%22Pinto%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Eric%22%2C%22lastName%22%3A%22Komena%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patricia%22%2C%22lastName%22%3A%22Lelo%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Winnie%22%2C%22lastName%22%3A%22Muyindike%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%22%2C%22lastName%22%3A%22Euvrard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Stephany%20N.%22%2C%22lastName%22%3A%22Duda%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22N.%20Sarita%22%2C%22lastName%22%3A%22Shah%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Samyra%20R.%22%2C%22lastName%22%3A%22Cox%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marie%22%2C%22lastName%22%3A%22Ballif%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lukas%22%2C%22lastName%22%3A%22Fenner%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22IeDEA%20global%20consortium%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Towards%20the%20%26%23039%3BEnd%20TB%20Strategy%26%23039%3B%20targets%2C%20the%20WHO%20recommends%20the%20provision%20of%20tuberculosis%20%28TB%29%20preventive%20therapy%20%28TPT%29%20for%20high-risk%20groups%20including%20people%20living%20with%20HIV%20%28PLWH%29.%203%20years%20after%20the%20release%20of%20the%20updated%202020%20WHO%20guidelines%2C%20we%20investigated%20the%20implementation%20of%20TPT%20services%20at%20HIV%20clinics%20in%20low-income%20and%20middle-income%20countries%20%28LMICs%29%2C%20focusing%20on%20TB%20screening%2C%20populations%20eligible%20for%20TPT%20and%20available%20TPT%20regimens.%5CnMETHODS%3A%20In%202023%2C%20we%20surveyed%20HIV%20care%20clinics%20in%20the%20International%20Epidemiology%20Databases%20to%20Evaluate%20AIDS%20consortium%20in%20Africa%2C%20the%20Asia-Pacific%20and%20Latin%20America%20and%20the%20Caribbean.%20We%20used%20descriptive%20statistics%20to%20summarise%20TPT%20implementation%20according%20to%20WHO%20guidelines%20and%20multivariable%20logistic%20regression%20models%20to%20estimate%20associations%20with%20clinic%20characteristics.%5CnRESULTS%3A%20Of%20172%20HIV%20clinics%20included%2C%20142%20%2883%25%29%20were%20in%20Africa%2C%2022%20%2813%25%29%20in%20the%20Asia-Pacific%20and%208%20%285%25%29%20in%20Latin%20America%3B%20108%20%2863%25%29%20were%20located%20in%20urban%20areas.%20After%20ruling%20out%20active%20TB%2C%20TPT%20was%20reportedly%20offered%20to%20PLWH%20%28122%20clinics%2C%2071%25%29%2C%20household%20contacts%20of%20individuals%20with%20active%20TB%20%28120%20clinics%2C%2070%25%29%20and%20other%20high-risk%20populations.%20TPT%20for%20PLWH%20was%20more%20frequently%20available%20in%20clinics%20in%20lower-income%20and%20low-middle-income%20countries%2C%20in%20high%20TB%20burden%20countries%2C%20and%20in%20district%20hospitals%20compared%20with%20other%20facility%20types.%20Clinics%20reported%20use%20of%20isoniazid-based%20%28160%20clinics%2C%2093%25%29%20and%20shorter%20rifamycin-based%20%28129%20clinics%2C%2075%25%29%20TPT%20regimens.%20Reported%20barriers%20to%20TPT%20initiation%20included%20patient%20refusal%20at%2071%20%2841%25%29%20and%20drug%20shortages%20at%2067%20%2839%25%29%20clinics.%5CnCONCLUSIONS%3A%20TPT%20was%20available%20at%20most%20HIV%20care%20clinics%20in%20LMICs%20but%20further%20efforts%20are%20needed%20to%20reinforce%20WHO%20recommendations%20and%20ensure%20that%20TPT%20is%20consistently%20accessible%20to%20people%20at%20higher%20risk%20of%20developing%20active%20TB%2C%20especially%20PLWH.%22%2C%22date%22%3A%222026-01-27%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1136%5C%2Fbmjgh-2024-018469%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%222059-7908%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22369YB7BV%22%2C%22NMNPNZRP%22%2C%22ZVWK2Q45%22%2C%22D9WC3N3V%22%2C%22TCMBXKKM%22%2C%228IRGNQWZ%22%2C%22F2Y6PLUL%22%2C%22ZBJI578D%22%2C%22YAE5EUBI%22%2C%223FNU2D64%22%2C%22BH3MKZCS%22%5D%2C%22dateModified%22%3A%222026-02-12T12%3A21%3A03Z%22%7D%7D%2C%7B%22key%22%3A%22YI2YYAMW%22%2C%22library%22%3A%7B%22id%22%3A2775998%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Moolla%20et%20al.%22%2C%22parsedDate%22%3A%222026-01%22%2C%22numChildren%22%3A1%7D%2C%22bib%22%3A%22%26lt%3Bdiv%20class%3D%26quot%3Bcsl-bib-body%26quot%3B%20style%3D%26quot%3Bline-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%26quot%3B%26gt%3B%5Cn%20%20%26lt%3Bdiv%20class%3D%26quot%3Bcsl-entry%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3B%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMoolla%2C%20Haroon%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BKassanjee%2C%20Reshma%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BEuvrard%2C%20Jonathan%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BMaartens%2C%20Gary%26lt%3B%5C%2Fspan%26gt%3B%3B%20%26lt%3Bspan%20style%3D%26quot%3Btext-decoration%3Anone%3B%26quot%3B%26gt%3BProzesky%2C%20Hans%20W.%26lt%3B%5C%2Fspan%26gt%3B%20et%20al.%26lt%3B%5C%2Fspan%26gt%3B%20%282026%29.%20Estimates%20and%20predictors%20of%20HIV%20viral%20non-suppression%20in%20South%20African%20adults%20on%20antiretroviral%20treatment.%20%26lt%3Bi%26gt%3BJournal%20of%20the%20International%20AIDS%20Society%26lt%3B%5C%2Fi%26gt%3B%2C%20%26lt%3Bi%26gt%3B29%26lt%3B%5C%2Fi%26gt%3B%20%281%29%2C%20S.%20e70076.%20%26lt%3Ba%20class%3D%26%23039%3Bzp-DOIURL%26%23039%3B%20href%3D%26%23039%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.70076%26%23039%3B%26gt%3Bhttp%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1002%5C%2Fjia2.70076%26lt%3B%5C%2Fa%26gt%3B.%26lt%3B%5C%2Fdiv%26gt%3B%5Cn%26lt%3B%5C%2Fdiv%26gt%3B%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Estimates%20and%20predictors%20of%20HIV%20viral%20non-suppression%20in%20South%20African%20adults%20on%20antiretroviral%20treatment%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Haroon%22%2C%22lastName%22%3A%22Moolla%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Reshma%22%2C%22lastName%22%3A%22Kassanjee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jonathan%22%2C%22lastName%22%3A%22Euvrard%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gary%22%2C%22lastName%22%3A%22Maartens%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hans%20W.%22%2C%22lastName%22%3A%22Prozesky%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Matthew%20P.%22%2C%22lastName%22%3A%22Fox%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Catherine%22%2C%22lastName%22%3A%22Orrell%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Geoffrey%22%2C%22lastName%22%3A%22Fatti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Frank%22%2C%22lastName%22%3A%22Tanser%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Gilles%22%2C%22lastName%22%3A%22Wandeler%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mary-Ann%22%2C%22lastName%22%3A%22Davies%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Renee%20de%22%2C%22lastName%22%3A%22Waal%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Patience%22%2C%22lastName%22%3A%22Nyakato%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Leigh%20F.%22%2C%22lastName%22%3A%22Johnson%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22name%22%3A%22International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20Southern%20Africa%20%28IeDEA%5Cu2010SA%29%20Collaboration%22%7D%5D%2C%22abstractNote%22%3A%22INTRODUCTION%3A%20Viral%20suppression%20estimates%20are%20essential%20for%20monitoring%20the%20performance%20of%20HIV%20programmes.%20South%20Africa%20introduced%20dolutegravir%20%28DTG%29-based%20antiretroviral%20therapy%20%28ART%29%20in%202019.%20We%20sought%20to%20generate%20updated%20estimates%20of%20viral%20suppression%20in%20South%20African%20adults%20on%20ART%20and%20investigate%20predictors%20of%20viral%20non-suppression.%5CnMETHODS%3A%20This%20retrospective%20cohort%20study%20used%20data%20from%20seven%20South%20African%20cohorts%20participating%20in%20the%20International%20epidemiology%20Databases%20to%20Evaluate%20AIDS%20collaboration.%20Three%20main%20analyses%20were%20performed%20using%20a%20viral%20suppression%20threshold%20of%201000%20HIV%20RNA%20copies%5C%2Fml.%20In%20the%20first%20analysis%2C%20we%20fitted%20a%20logistic%20regression%20model%20using%20the%20full%20data%20from%20the%20study%20period%20%282005-2023%29.%20Then%2C%20in%20two%20causal%20analyses%2C%20we%20used%20logistic%20regression%20with%20inverse%20probability%20weighting%20to%20assess%20the%20effects%20of%20starting%20ART%20on%20DTG-based%20regimens%20%28as%20opposed%20to%20starting%20on%20non-DTG-based%20ART%29%20and%20switching%20to%20DTG%20while%20virally%20suppressed%20%28compared%20to%20remaining%20on%20non-DTG-based%20ART%29.%20In%20sensitivity%20analyses%2C%20we%20reduced%20the%20suppression%20threshold%20to%20400%20copies%5C%2Fml%20and%20excluded%20those%20with%20missing%20baseline%20CD4%2B%20cell%20count%20measurements.%5CnRESULTS%3A%20There%20were%20380%2C720%20participants%20contributing%202%2C090%2C912%20person-years%20of%20observation.%20Most%20participants%20were%20female%20%2864.7%25%29%2C%20and%20the%20median%20age%20at%20ART%20initiation%20was%2035.0%20years%20%28interquartile%20range%2028.9-42.3%29.%20Viral%20suppression%20increased%20over%20time%2C%20reaching%2095.9%25%20in%202023.%20Twenty-one%20percent%20of%20participants%20either%20started%20ART%20on%20DTG-based%20regimens%20%287.1%25%29%20or%20switched%20to%20DTG-based%20regimens%20from%20a%20virally%20suppressed%20state%20%2814.0%25%29.%20DTG-based%20ART%20was%20protective%20against%20viral%20non-suppression%20in%20both%20causal%20models%2C%20with%20adjusted%20odds%20ratios%20of%200.54%20%2895%25%20confidence%20interval%20%5BCI%5D%200.48-0.61%29%20and%200.36%20%2895%25%20CI%200.32-0.39%29%20for%20those%20initiating%20ART%20on%20DTG%20and%20those%20switching%20to%20DTG%2C%20respectively.%20A%20history%20of%20ART%20interruption%20was%20strongly%20associated%20with%20viral%20non-suppression%2C%20with%20adjusted%20odds%20ratios%20ranging%20from%202.49%20to%204.55.%20The%20odds%20of%20non-suppression%20decreased%20with%20increasing%20age%2C%20increasing%20duration%20on%20ART%20and%20increasing%20baseline%20CD4%2B%20cell%20count.%20Results%20were%20consistent%20across%20sensitivity%20analyses.%5CnCONCLUSIONS%3A%20DTG-based%20regimens%20improve%20viral%20suppression%20among%20both%20ART-na%5Cu00efve%20individuals%20and%20those%20transitioning%20while%20suppressed.%20ART%20interruptions%20pose%20a%20risk%20to%20the%20sustained%20success%20of%20ART%20programmes%20and%20may%20further%20impede%20efforts%20to%20recover%20from%20the%20impacts%20of%20recent%20funding%20cuts.%22%2C%22date%22%3A%222026-01%22%2C%22section%22%3A%22%22%2C%22partNumber%22%3A%22%22%2C%22partTitle%22%3A%22%22%2C%22DOI%22%3A%2210.1002%5C%2Fjia2.70076%22%2C%22citationKey%22%3A%22%22%2C%22url%22%3A%22%22%2C%22PMID%22%3A%22%22%2C%22PMCID%22%3A%22%22%2C%22ISSN%22%3A%221758-2652%22%2C%22language%22%3A%22eng%22%2C%22collections%22%3A%5B%22NMNPNZRP%22%2C%22TCMBXKKM%22%2C%22BH3MKZCS%22%5D%2C%22dateModified%22%3A%222026-02-12T12%3A46%3A50Z%22%7D%7D%5D%7D
Schmutz, Remo; Banholzer, Nicolas; Shearer, Kate; Golub, Jonathan E.; Cortes, Claudia P. et al. (2026). The implementation of tuberculosis preventive therapy in HIV care clinics in Africa, Asia and Latin America: a multiregional site survey.
BMJ Global Health,
11 (1), S. e018469.
http://doi.org/10.1136/bmjgh-2024-018469.
Moolla, Haroon; Kassanjee, Reshma; Euvrard, Jonathan; Maartens, Gary; Prozesky, Hans W. et al. (2026). Estimates and predictors of HIV viral non-suppression in South African adults on antiretroviral treatment.
Journal of the International AIDS Society,
29 (1), S. e70076.
http://doi.org/10.1002/jia2.70076.